CAB News

CAB Now Accepting Applications for Bioactive Materials-CAB Research Excellence Awards

Yue Zhang — Thu, 15 Oct 2026 06:26:16 GMT

The Chinese Association for Biomaterials (CAB) is pleased to announce the launch of a monthly CAB webinar initiative designed to recognize and promote outstanding investigators whose research advances biomaterials science, biomedical innovation, and translational healthcare solutions.

Through this initiative, CAB aims to provide a professional platform for emerging leaders to present their work, foster scientific exchange across the biomaterials community, and strengthen connections among researchers in academia, industry, medicine, and translational science.

We invite applications and nominations for outstanding junior faculty members whose work advances biomaterials research, biomedical innovation, and translational healthcare solutions.

Award Details

CAB will select two outstanding speakers from the webinar to receive the Bioactive Materials-CAB Research Excellence Awards. Each selected awardee will receive a $500 award, with a total award pool of $1000. Selected awardees will be invited to present their research as featured speakers in the CAB Workshop if time is available.

Applicants and nominees who wish to be considered for the Bioactive Materials-CAB Research Excellence Award are encouraged to join CAB prior to application submission or nomination acceptance. Active CAB membership is required for award consideration.

Eligibility and Nomination*

Applicants should meet the following criteria:

Hold a junior faculty appointment at the level of Assistant Professor or Associate Professor, or an equivalent early-career independent investigator position.
Conduct research in biomaterials science, biomedical engineering, tissue engineering, regenerative medicine, drug delivery, medical devices, or related areas.
Propose a webinar topic aligned with CAB’s mission to advance biomaterials research, innovation, translation, and community engagement.
Be available to present in the CAB webinar series during the designated webinar period.
Hold an active CAB membership at the time of application.

*Both self-nominations and nominations by CAB members, mentors, colleagues, or institutional leaders are welcome. For nominations submitted by another individual, the nominee should be aware of and agree to participate in the webinar series if selected.

Webinar Theme

The CAB webinar series will feature research aligned with the theme:

Shaping the Living Blueprint through Advanced Biomaterials

We welcome presentations addressing cutting-edge advances in biomaterials science, translation of basic research into clinical or industrial applications, and innovative healthcare solutions. Areas of interest include, but are not limited to:

Biomaterials for Tissue engineering & Regenerative medicine
Implants and medical devices
Biomaterial design, fabrication, and characterization
Drug delivery, immunoengineering, and cell-material interactions
Engineering tissues, organoids, and disease models
Clinical, industrial, and entrepreneurial translation of biomaterials technologies
AI/ML driven biomaterial design or applications

Consistent with CAB’s commitment to scientific excellence, collaboration, and inclusion, we strongly encourage applications from investigators representing diverse backgrounds, geographic regions, institution types, research perspectives, and groups historically underrepresented.

Selection Criteria

Applications will be reviewed by the CAB organizing committee based on the following criteria:

Scientific merit and originality of the proposed presentation
Alignment with the CAB webinar theme and biomaterials research priorities
Potential impact on biomaterials science, healthcare innovation, or clinical/industrial translation
Clarity and significance of the proposed webinar topic
Applicant’s record of scholarly achievement and promise as an emerging leader
Contribution to the diversity of topics, perspectives, institutions, and backgrounds represented in the webinar series

Proposed Timeline

Call for Applications: Jul-Oct 2026
CAB will circulate this announcement through the CAB network and broader biomaterials and biomedical engineering communities. Applications and nominations must be submitted by October 31, 2026.
Review and Selection: Oct-Nov 2026
The CAB organizing committee will review applications based on scientific merit, originality, alignment with the webinar theme, and potential impact on biomaterials research and translation.
CAB monthly Webinar Series: Fall 2026

Selected awardees will present their work in the CAB monthly webinar series. Each webinar will provide a platform for scientific exchange, networking, and visibility for early-career investigators in the biomaterials community.

Application/Nomination Materials:

Interested Assistant Professors and Associate Professors should submit a brief application package that includes:

1. Current curriculum vitae (10 pages)

2. Proposed presentation title

3. Brief abstract describing the webinar presentation and its relevance to advanced biomaterials, tissue engineering, clinical translation, or related areas

4. A recent photo of the presenter

Submission Contact

Please send application materials to the CAB organizing committee through:

Dr. Ke Huang

Texas A&M University

kehuang@tamu.edu

Organizing Team

Yi Hong, University of Texas at Arlington; Ke Huang, Texas A&M University; Aijun Wang, University of California, Davis; Cunjiang Yu, University of Illinois Urbana-Champaign; Guohao Dai, Northeastern University; Ying Mei, Clemson University; Bin Duan, University of Nebraska Medical Center; Feng Zhao, Texas A&M University; Zhen Ma, Syracuse University.

2027 CAB Awards

Yue Zhang — Thu, 15 Oct 2026 06:19:27 GMT

The Chinese Association for Biomaterials (CAB) is now accepting nominations for its 2027 CAB Awards:

CAB Global Biomaterials Leadership Award – Recognizes individuals who have made exceptional contributions and demonstrated global leadership in biomaterials research and translation. Winners receive a $1,000 cash honorarium and a trophy. No more than two awards are given each year. This is the only CAB award that does not require CAB membership to receive.
Bioactive Materials CAB Impact Award – Recognizes senior investigators who have made significant and sustained contributions to biomaterials or closely related areas, as well as service to CAB and the biomaterials community. Winners receive a $750 cash honorarium. No more than two awards are given each year. Eligible nominees must hold the rank of Full Professor or an equivalent senior independent investigator position and must have published at least one paper in Bioactive Materials, or have a manuscript currently submitted to, under review by, or accepted for publication in Bioactive Materials.
CAB Distinguished Leadership and Service Award – Recognizes an individual who has demonstrated outstanding leadership and exceptional service to the CAB community.
CAB Trainee/Young/Mid-Career Investigator Awards – Recognize individuals who have demonstrated significant achievements in biomaterials research. No more than two awards are given each year in each of the three categories:
- Trainee Award: Candidates must be within 4 years of receiving their PhD and should not exceed the rank of Postdoctoral Fellow or equivalent.
- Young Investigator Award: Candidates must be within 10 years of receiving their PhD and should not exceed the rank of Assistant Professor or equivalent.
- Mid-Career Investigator Award: Candidates must carry a rank higher than Assistant Professor or equivalent and should not exceed the rank of Associate Professor or equivalent.
Bioactive Materials-CAB Research Excellence Awards – Recognize outstanding junior faculty members. Detailed eligibility criteria and nomination instructions will be provided in a separate award announcement.

CAB membership is required to receive these awards, with the exception of the CAB Global Biomaterials Leadership Award. Nominations for nominees who are not a CAB member by the nomination deadline will not be considered.

Each CAB member can nominate up to two candidates. Each nomination should include a curriculum vitae (10 pages maximum) of the nominee together with one nomination letter from the nominator. Nomination packages should be sent to the CAB Award Committee co-chairs, Prof. Ying Mei at mei@clemson.edu and Prof. Zhen Ma at zma112@syr.edu by November 8, 2026. The awardees will be notified by e-mail. All recipients will receive a plaque and be recognized at the CAB Annual Meeting/workshop during the SFB 2027 Annual Meeting & Exposition (April 28 –May 1, 2027) in Seattle, Washington State, USA.

2023 CAB Award

Nan Zhao — Wed, 10 May 2023 22:56:00 GMT

We are pleased to announce the winners of the CAB Awards in 2023!

CAB Global Biomaterials Leadership Award: Song Li, Ph.D., UCLA and William R. Wagner, Ph.D., University of Pittsburg

CAB Distinguished Leadership and Service Award: Jian Yang, Ph.D., Penn State University

CAB Mid-Career Investigator Award: Jiangbing Zhou, Ph.D., Yale University and Cunjiang Yu, Ph.D., Penn State University

CAB Young Investigator Award: Jun Chen, Ph.D., UCLA, Zheng Yan, Ph.D., University of Missouri, Columbia, and Jiajia Xue, Ph.D., Beijing University of Chemical Technology

CAB Trainee Award: Congyang Mao, Ph.D., The University of Hong Kong and Xi Wang, Ph.D., Harvard University

Congratulations to all awardees!

Chinese Association for Biomaterials (CAB) is calling for nominations for the following awards:

Nan Zhao — Fri, 13 Jan 2023 01:39:38 GMT

The CAB Global Biomaterials Leadership Award recognizes individuals who have made exceptional contributions and demonstrated global leadership in the field of biomaterials research and translation. The winner receives a cash honorarium of $2000 and a trophy. No more than two awards are given each year.

The CAB Distinguished Leadership and Service Award recognizes an individual who has demonstrated outstanding leadership and exceptional services to the CAB community.

The CAB Trainee/Young/Mid-Career Investigator Awards recognize individuals who have demonstrated significant achievements in the field of biomaterials research. CAB membership is required for our Chinese colleagues to receive these awards. No more than two awards are given each year for each of the three categories.

 The candidates for the CAB Trainee Award must be within 3 years of receipt of PhD degree and should not exceed the rank of Post-doctoral Fellow or equivalent.

 The candidates for the CAB Young Investigator Award must be within 10 years of receipt of PhD degree and should not exceed the rank of Assistant Professor or equivalent.

 The candidates for the CAB Mid-Career Investigator Award must carry a rank higher than Assistant Professor or equivalent and should not exceed the rank of Associate Professor or equivalent.

Each CAB member can nominate up to two candidates. Each nomination should include a curriculum vitae of the nominee together with one nomination letter from the nominator. All nominations will be considered by the CAB Award Committee. Nomination packages should be sent to the CAB Award Committee co-chairs, Professor Ke Cheng at Ke_Cheng@unc.edu and Professor Xiaoming He at shawnhe@umd.edu by January 31, 2023. The awardees will be notified by e-mail. All the recipients will receive a plaque and be recognized at the CAB Annual Meeting during the Society for Biomaterials Annual Meeting 2023 in San Diego, USA (April 27-30, 2023).

CAB reception and award ceremony at 2022 SFB

Malcolm Xing — Tue, 03 May 2022 23:52:08 GMT

The unprecedent COVID-19 pandemic had interrupted all in-person conferences and meetings. Now CAB Reception and Award Ceremony for 2022 is finally back with an exciting schedule to bring you the best gathering and networking you expect from CAB. This year’s reception took place in Baltimore, MD on April 28, 2022, as a special even at the SFB annual meeting.

More than 50 attendees from all over the world gathered together to celebrate the CAB Awards for 2022, among them, two internationally-renowned professors, Dr. Guillermo Ameer and Dr. Xuesi Chen, were the awardees of the Global Biomaterials Leadership Award.

Moreover, a dinner at the local restaurant “Red Pepper” attended by all witnessed how close our CAB family could be. It is really exciting that our CAB family is growing every day, and we appreciate your continuous support and patriotism, so please join us in the next events sponsored by CAB.

CAB Awards in 2022 SFB

Malcolm Xing — Tue, 03 May 2022 15:49:46 GMT

We are pleased to announce the winners of the CAB Awards in 2022! The CAB Global Biomaterials Leadership Award is awarded to Prof. Guillermo Ameer and Prof. Xuesi Chen to recognize their distinguished leadership in advancing the basic and translational research in biomaterials. The CAB Mid-Career, Young Investigator, and Trainee Awards go to Prof. Guohao Dai, Prof. YiZhou Dong, Prof. Xin Zhao, Prof. Guojun Chen, Prof. Yu Huang, Dr. Yang Liu, and Dr. Yuyuan Wang, respectively, for their excellent achievements in biomaterials research. Please join us to congratulate all the CAB award winners!

Global Biomaterials Leadership Award

· Dr Guillermo Ameer (Northwestern University)
· Dr Xuesi Chen (Chinese Academy of Sciences)

Mid-Career Award

· Dr Guohao Dai (Northeastern University)
·
- Dr Yizhou Dong (The Ohio State University)
Dr Xin Zhao (The Polytechnique University of Hong Kong)

Young Investigator Award

· Dr Guojun Chen (McGill University)
· Dr Yu Huang (Utah State University)

Trainee Award

· Dr Yang Liu (University of Connecticut, Storrs Campus)
· Dr Yuyuan Wang (University of Wisconsin-Madison)

Postdoctoral Fellow Position in Bone Biology and Stem Cell Biology at Stanford University

Mon, 17 Jan 2022 00:50:57 GMT

Contact Info: Yunzhi Peter Yang, ypyang@stanford.edu

Description:

One postdoctoral position in bone biology and/or stem cell biology is available immediately in the lab of Professor Yunzhi Peter Yang, Departments of Orthopedic Surgery at Stanford University at https://med.stanford.edu/yanglab.html. The candidates with strong biology and surgery experimental experience and interest in the areas of tissue regeneration is sought to participate in the NIH and DOD funded projects. The Lab particularly emphasizes development of multidisciplinary and novel approaches to address relevant biomedical questions in musculoskeletal tissue applications. Highly motivated candidates with experimental background, strong academic and publication record, and the ability to work independently and collaboratively with a strong commitment are invited to apply. Interested candidates should send a cover letter, their CV, and the names and contact information of three references electronically to the email address given below, ypyang@stanford.edu. The positions are open immediately.

Qualifications:

The postdoctoral fellow will participate in the projects involving stem cells and requires a strong background in stem cell biology, bone biology, genetic editing and surgical skills in orthopedic trauma and tendon injury in vivo models. The applicants who have abundant experience with cell culture, RNA extraction, qRT-PCR, bioinformatic analysis, tissue analysis techniques, such as paraffin embedding, tissue sectioning, immunohistological staining, histomorphometry, micro-CT, and mechanical tests, and orthopaedic surgery for rodents are highly encouraged for application.

First Impact Factor of Bioactive Materials released: 8.724

Tue, 07 Jul 2020 14:00:00 GMT

The first Impact Factor of Bioactive Materials was released and the journal achieved an impact factor of 8.724. It ranks 2nd out of 38 journals in Materials Science, Biomaterials category and 5th out of 87 journals in Engineering, Biomedical category. Bioactive Materials is an international, peer-reviewed research publication covering all aspects of bioactive materials (http://www.keaipublishing.com/en/journals/bioactive-materials/). Congratulations to all editorial board members!

Dr Hu Yang named new chair of chemical and biochemical engineering at Missouri S&T

Mon, 18 May 2020 14:00:00 GMT

Dr. Hu Yang will begin his new role as the chair of the chemical and biochemical engineering department at Missouri S&T on 8/1/2020. Yang joins Missouri S&T from Virginia Commonwealth University (VCU) where he is the Qimonda Endowed Chair in chemical and life science engineering, biomedical engineering, and pharmaceutics. Congratulations!

Source: Missouri S&T

The Chinese Association for Biomaterials (CAB) Awards in 2020

Thu, 07 May 2020 14:00:00 GMT

We are pleased to announce the winners of the CAB Awards in 2020! The CAB Global Biomaterials Leadership Award is awarded to Prof. Kam W Leong and Prof. David L. Kaplan to recognize their distinguished leadership in advancing the basic and translational research in biomaterials. The CAB Mid-Career, Young Investigator, and Trainee Awards go to Prof. Jingwei Xie, Prof. Yi Hong, Prof. Y. Shrike Zhang, Prof. Eun Ji Chung, Dr. Xuehui Zhang, Dr. Peng Shi, and Dr. Guomin Wang, respectively, for their excellent achievements in biomaterials research. Please join us to congratulate all the CAB award winners!

CAB Global Biomaterials Leadership Award

Prof. Kam W Leong (Columbia University)

Prof. David L. Kaplan (Tufts University)

CAB Mid-Career Award

Prof. Jingwei Xie (University of Nebraska Medical Center)

Prof. Yi Hong (University of Texas at Arlington)

CAB Young Investigator Award

Prof. Y. Shrike Zhang (Harvard Medical School)

Prof. Eun Ji Chung (University of Southern California)

CAB Trainee Award

Dr. Xuehui Zhang (Peking University School and Hospital of Stomatology)

Dr. Peng Shi (The Pennsylvania State University)

Dr. Guomin Wang (City University of Hong Kong)

Biography of awardees

Vitamin Lipid Nanoparticle-enabled Cell Therapy for Sepsis

Fri, 14 Feb 2020 22:00:00 GMT

Sepsis, a severe condition caused by infections, affects millions of people worldwide every year and remains the leading cause of death in hospitals. In addition, multidrug-resistant (MDR) bacteria have become an additional challenge in the treatment of sepsis and thus, effective therapeutics are urgently needed. A recent paper from Dr. Yizhou Dong and his collaborators at The Ohio State University reported a novel approach for overcoming MDR bacteria-induced sepsis that combines vitamin derived lipid nanoparticles with adoptive macrophage therapy. In this study, the adoptive transfer of macrophages containing antimicrobial peptides in the lysosomes (MACs) reduced bacterial burden and improve survival in the sepsis mouse models. This work was published in Nature Nanotechnology (https://www.nature.com/articles/s41565-019-0600-1).

A “Subcutaneous Pancreas"

Fri, 14 Feb 2020 13:00:00 GMT

Cell replacement therapy such as intrahepatic transplantation of donor islets is relatively successful for type 1 diabetes in some patients. However, there are a number of limitations including immediate blood-mediated inflammatory response, potential risks of thrombosis and localized steatosis, and inability to retrieve or replace failed cells. Subcutaneous site is less invasive and easier-to-access but lacks sufficient vasculature to support the islet function. Dr. Minglin Ma and his collaborators reported a pre-vascularized islet construct that functioned in the subcutaneous site and corrected diabetes in mice for 3 months. (https://doi.org/10.1038/s41467-019-12373-5)

Coin-Sized Smart Insulin Patch Regulates Blood Sugar in Pigs

Wed, 12 Feb 2020 13:00:00 GMT

Glucose-responsive insulin delivery systems that mimic pancreatic endocrine function could enhance health and improve quality of life for people with type 1 and type 2 diabetes with reduced β-cell function. Recently, a research team led by Zhen Gu, a professor of bioengineering at the UCLA Samueli School of Engineering and a member of CAB, developed a smart insulin-delivery patch that could one day monitor and manage glucose levels in people with diabetes and deliver necessary insulin dosage. In the experiments, one quarter-sized patch successfully controlled glucose levels in pigs (> 25 kg) with type I diabetes for about 20 hours. A study describing the research in which the patch was published in Nature Biomedical Engineering (https://doi.org/10.1038/s41551-019-0508-y).

CAB-SFB Workshop: Biomaterials Science Excellence and Technology Transition

Sat, 20 Apr 2019 18:55:16 GMT

In collaboration with Society for Biomaterials (SFB), CAB successfully organized a Biomaterials Science Excellence and Technology Translation Workshop at the SFB Annual Meeting in Seattle, WA on April 3, 2019. The workshop included invited presentations/lectures from global biomaterial leaders in biomaterials science and a panel discussion to discuss biomaterial innovation, international collaboration, venture investment, company startups, intellectual property, and other key elements en route to successful biomaterial technology translation. CAB also took this opportunity to present awards to a few outstanding scientists in three categories: CAB Global Biomaterials Leadership Award, CAB Mid-Career Investigator Award, and CAB Young Investigator Award.

CAB Global Biomaterials Leadership Awards

Prof. Cato Laurencin (Middle) Prof. Changsheng Liu (Middle)

Cato Laurencin, MD, PhD

Cato T. Laurencin, M.D., Ph.D. is a University Professor at the University of Connecticut (the 8^th to be designated in the institution’s over 140 year history). He is the Albert and Wilda Van Dusen Distinguished Endowed Professor of Orthopaedic Surgery. He is Professor of Chemical, and Biomolecular Engineering, Professor of Materials Science and Engineering, and Professor of Biomedical Engineering at UCONN. Dr. Laurencin is the Founder and Director of the Raymond and Beverly Sackler Center for Biomedical, Biological, Physical and Engineering Sciences at the University of Connecticut and C.E.O. of The Connecticut Convergence Institute for Translation in Regenerative Engineering at UCONN. Dr. Laurencin is an elected member of the National Academy of Medicine and an elected member of the National Academy of Engineering. Internationally, he is an elected Fellow of the African Academy of Sciences, an elected Fellow (Foreign) of the India National Academy of Sciences, an elected Fellow (Foreign) of the Indian National Academy of Engineering and is a Fellow of The World Academy of Sciences. Dr. Laurencin is an Academician and Member (Foreign) of the Chinese Academy of Engineering. This award recognizes his global leadership in biomaterials innovation and technology translation.

Changsheng Liu, PhD

Changsheng Liu, PhD. is the Cheung Kong Scholar Professor of East China University of Science and Technology (ECUST), Academician of Chinese Academy of Sciences. Dr. Liu is currently the vice President of ECUST，director of Engineering Research Center for Biomaterial Materials of Ministry of Education，and director of Key Laboratory for Ultrafine Materials of Ministry of Education. His major research areas include biomaterials and tissue regeneration, fabrication of inductive growth factors, and designing of bioactive skeletal substitutes for bone repair. He developed a few novel biomaterials and received CFDA approvals. He was elected to the fellow of international Biomaterials Science and Engineering (2012) and American Institute for Medical and Biological Engineering (AIMBE) Fellow (2018). He was also a recipient of Ho Leung Ho Lee Foundation-Prize for Scientific and Technological Innovation Award (2007), the National Award for Natural Science (The Second Place) in 2014, the National Award for Science and Technology Progress (The Second Place) in 2003. This award recognizes his global leadership in biomaterials innovation and technology translation.

CAB Mid-Career Investigator Awards

Prof. Liming Bian (Middle) Prof. Qiaobing Xu (Middle) Prof. Donghui Zhu (Middle)

Liming Bian, PhD

Liming Bian, PhD is currently an Associate Professor in the Department of Biomedical Engineering at the Chinese University of Hong Kong. He was recognized for his innovative work on biofunctionalizing biomaterials for stem cell-based regenerative therapies. The findings from these studies provide the critical insights to the design of polymeric biomaterials with molecular dynamics for enhanced biomaterial functions. Dr. Bian’s research work has been published in the leading journals including PNAS, JACS, Nano Letters, Biomaterials, Advanced Materials, Advanced Functional Materials, Advanced Science, ACS Nano, ACS Central Science, Macromolecules, Small, and Chemistry of Materials. He was a receipent of BMES CMBE Rising Star Award, CHUK Young Researcher Award, and Asian Biomaterials Congress Young Investigator Award.

Qiaobing Xu, PhD

Qiaobing Xu, PhD is an Associate Professor of Biomedical Engineering at Tufts University. He was recognized for his contribution on developing synthetic biodegradable lipid like materials for intracellular protein delivery for therapeutics including rare diseases and genome editing. His work has been published in leading journals such as Nature, Nature BME, JCI, PNAS, JACS, Angew Chem, and highlighted by Science and news media such as Genomeweb and C&E News. Dr. Xu has received several notable awards, including Pew Scholar for Biomedical Sciences from Pew Charitable Trusts, NSF CAREER award and the Rising Star Award from BMES/CMBE program.

Donghui Zhu, PhD

Donghui Zhu, PhD is an Associate Professor of Biomedical Engineering at University of North Texas. He was recognized for his contribution to biodegradable metallic biomaterials for regenerative and translational medicine. Dr. Zhu have published over 50 peer-reviewed papers in prestigious journals such as Blood, Nature Neuroscience, Advanced Science, and Biomaterials. He was a recipient of Outstanding Junior Faculty Research Award from College of Engineering of North Carolina AT State University. He has recently received two NIH R01 grants.

CAB Young Investigator Awards

Prof. Bin Duan (Middle) Prof. Michael Mitchell (Middle)

Bin Duan, PhD

Bin Duan, PhD is an Assistant Professor at University of Nebraska Medical Center. He was recognized for his contribution on 3D bioprinting of living tissues to study stem cell functions. He has published more than 50 peer-reviewed papers, 8 book chapters, and 4 patents. Dr. Duan was a recipient of American Heart Association (AHA) Postdoctoral Fellowship, AHA Scientist Development Grant Award, Gilmore Distinguished New Investigator Award at UNMC, and Orthopedic Biomaterials SIG Outstanding Abstract Award at 2019 SFB Annual Conference (2019). His research has been funded by AHA SDG, and NIH (R01 and R21 as PI).

Michael Mitchell, PhD

Michael Michelle, PhD is a Skirkanich Assistant Professor of Innovation in the Department of Bioengineering at the University of Pennsylvania. He was recognized for his contribution on developing novel drug and gene delivery technologies for regenerative medicine and immunotherapy. He has received numerous award at his early career stage. To name a few, he was a recipient of NIH New Innovator Award, BMES Rising Star Award in Cellular and Molecular Bioengineering, Selected Delegate of Academy of Achievement International Summit, Burroughs Wellcome Fund Career Award at the Scientific Interface (CASI), and Skirkanich Assistant Professor of Innovation Endowed Chair.

Workshop Panelists

Qing Liu, PhD, President and CEO

Beijing Advanced Medical Technologies

President and CEO of Beijing Advanced Medical Technologies (AMT)，Director of Engineering Research Center for Biomaterials & Medical Device 3D Printing at Fudan Zhangjiang Institute, adjunct Professor at Tongji University, Shanghai, China. Dr. Liu received his Ph.D. degree in biomaterials from Twente University (the Netherlands) in 1997, He did his postdoctoral training at Rice University from 1997-1999. Dr. Liu has over 25 years of R&D experience in biomaterials and medical device. From 2002-2007, Dr. Liu served as Director of Biomaterials R&D at Celgene Corporation where he directed the stem cell and biomaterial combination product development programs. He co-founded 3D Biotek in 2007 and served as CEO/CSO. In 2011, he founded AMT to develop totally bioresorbable coronary and peripheral stents using proprietary 3D printing technologies.

Lihua Zheng, JD, PhD, Partner

Zheng & Karg LLP

Dr. Lihua Zheng, is a founding partner and owner of Zheng & Karg LLP. Dr. Zheng advises on both corporate and intellectual property aspects of technology commercialization. He specializes in IP licensing, venture capital financing, patent portfolio management, corporate partnering, and joint ventures. Dr. Zheng is licensed in the State of New York and the United States District Court for the Eastern District of New York. He is also a registered patent attorney at the United States Patent and Trademark Office. Dr. Zheng’s practice encompasses a broad range of technical areas, including biomaterials, biotechnologies, pharmaceuticals, nutraceuticals, botanical medicines, medical devices, healthcare, medical devices, and consumer products. With deep understandings of both technical and legal nature, Dr. Zheng is particularly experienced in serving companies in the healthcare industry such as life sciences and pharmaceutical companies.

James Malayter, Managing Partner, Senior VP

Acuitive Technologies, Inc.

Mr. Malayter provides extensive product development and marketing experience gained from his years working in executive management positions for big companies such as Pfizer, Howmedica and Zimmer. He has also played a pivotal role in guiding several start-up companies such as Osteonics, Implex Corp. and Pipeline Orthopedics to successful exits. His tenure in teaching Biology, Chemistry and Physics assisted his ability to communicate complex concepts into tangible medical devices that are designed to improve patient clinical outcomes. Through his direct interaction with surgeons and scientists he has helped to develop several technologies that have defined a new standard in their respective market segments (i.e. Trabecular Metal). Mr. Malayter is currently a Founding Partner in Acuitive Technologies, Inc.

Cato T. Laurencin, MD, PhD, University Professor

University of Connecticut

Cato T. Laurencin, M.D., Ph.D. is a University Professor at the University of Connecticut (the 8^th to be designated in the institution’s over 140-year history). He is the Albert and Wilda Van Dusen Distinguished Endowed Professor of Orthopaedic Surgery. He is Professor of Chemical, and Biomolecular Engineering, Professor of Materials Science and Engineering, and Professor of Biomedical Engineering at UCONN. Dr. Laurencin is the Founder and Director of the Raymond and Beverly Sackler Center for Biomedical, Biological, Physical and Engineering Sciences at the University of Connecticut and C.E.O. of The Connecticut Convergence Institute for Translation in Regenerative Engineering at UCONN. Dr. Laurencin is an elected member of the National Academy of Medicine and an elected member of the National Academy of Engineering. Internationally, he is an elected Fellow of the African Academy of Sciences, an elected Fellow (Foreign) of the India National Academy of Sciences, an elected Fellow (Foreign) of the Indian National Academy of Engineering and is a Fellow of The World Academy of Sciences. Dr. Laurencin is an Academician and Member (Foreign) of the Chinese Academy of Engineering.

Changsheng Liu, PhD, VP

East China University of Science and Technology (ECUST)

Hao Li, PhD

Professor of University of Missouri, Columbia

CEO of Nanova Inc.

Hao Li is a professor in the Mechanical and Aerospace Engineering Department at the University of Missouri. Dr. Li’s research focuses on synthesis, characterization and application of novel nanomaterials and biomaterials. Dr. Li is an inventor of a biomimetic nanocomposite technology. Based on this technology, several dental and orthopedic products have been cleared by FDA and are currently available in the market. Li’s research has been funded by the NSF, NIH and other federal agencies and he is also a recipient of the NSF’s CAREER award. Dr. Li is also CEO and co-founder of Nanova Inc., a biotech start-up based in Columbia, MO. Nanova is currently working on three areas: medical devices, drug discovery and development, and environmental technologies. With both entrepreneurial and academic experience, Dr. Li is trying to build bridges between academia, industry, and financial firms in order to create unique values to the society. Dr. Li is trained as a materials scientist with bachelor and master degree from Xi’an Jiaotong University and Ph.D. degree from Stevens Institute of Technology and also obtained postdoctoral training from Brown University in nanotechnology.

CAB thanks for the generous donations from the following workshop sponsors:

Nanova Inc. Beijing Advanced Medical Technologies

Zheng&Karg LLP Bioactive Materials

The Chinese Association for Biomaterials (CAB) Awards

Thu, 31 Aug 2017 23:25:57 GMT

The Chinese Association for Biomaterials (CAB) Young Investigator Award recognizes an individual who has demonstrated outstanding achievement and leadership in biomaterial-related research and profession. Candidates for the CAB Young Investigator Award must be under 45 years old. If they work in an academic institution, they must not hold a full professor position at the time of nomination. The 2017 CAB Young Investigator Awardees were all invited to present at the Symposium of “Biomaterials Science and Translational Medicine” at the 254th American Chemical Society National Meeting, Washington DC during August 20-24, 2017. The symposium under the Division of Polymeric Materials Science and Engineering of ACS was organized by CAB and co-sponsored by the “Bioactive Materials” Journal.

CAB President joins University of Kentucky as the Chair of Biomedical Engineering

Tue, 22 Aug 2017 23:11:38 GMT

Guigen Zhang joins the University of Kentucky College of Engineering as the inaugural F. Joseph Halcomb III, M.D. Chair in Biomedical Engineering, and the Department Chair of the F. Joseph Halcomb III, M.D. Department of Biomedical Engineering. Congratulations.

Professor Jian Yang named AIMBE fellow

Fri, 11 Mar 2016 12:33:42 GMT

Professor Jian Yang, PhD, from Penn State University was elected AIMBE fellow! Congratulations!